MedStar Washington Hospital Center Offers FARAPULSE™ Pulsed Field Ablation, a Regional First for Atrial Fibrillation Treatment

Thursday, May 16, 2024

MedStar Washington Hospital Center has introduced an innovative therapy for treating atrial fibrillation (AFib), the most prevalent heart rhythm disorder in adults, to the greater Washington and Baltimore areas.

Utilizing the FARAPULSE™ Pulsed Field Ablation (PFA) System, doctors successfully treated five patients on April 22, all of whom were discharged on the same day. Since then, an additional 55 patients have been safely and effectively treated with this groundbreaking technology.

Traditional AFib treatments have relied on heat or cold energy to disrupt abnormal electrical signals in the heart.

The new PFA technology delivers precise electrical pulses to selectively block irregular heart rhythms while minimizing damage to surrounding tissues.

Cardiac electrophysiologist at MedStar Washington Hospital Center, expressed satisfaction in offering the FARAPULSE Pulsed Field Ablation as it enables patients to return to normal heart rhythm safely and efficiently.

Emphasized the rising incidence of AFib and the importance of effective therapies like PFA in treating more patients, reducing complications, and improving outcomes.

During the PFA procedure, a catheter is inserted from the thigh vein into the heart, delivering high voltage pulses to deactivate heart cells transmitting abnormal electrical signals causing AFib.

This process is highly precise and preserves nearby normal tissues. Most patients currently undergoing pulsed field ablation experience paroxysmal AFib, where symptoms come and go.

MedStar Washington Hospital Center has been at the forefront of pulse field ablation for years, contributing to studies that have paved the way for this technology's adoption. The pivotal ADVENT clinical trial, in which the hospital participated, directly compared the efficacy and safety of FARAPULSE PFA against standard-of-care ablation.

The study concluded that PFA therapy is as safe and effective as conventional thermal ablation, with shorter procedure times and faster patient recovery.

It is estimated that around 12.1 million Americans will suffer from atrial fibrillation, a condition characterized by rapid and irregular quivering of the heart's upper chambers.

Individuals with AFib face an increased risk of stroke, heart failure, and other heart-related complications compared to those with normal heart rhythms.




Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024